Bridging Medical Knowledge: JenburktPharmaceuticals Ltd and NIMHANS Launch First-Ever Neuropathy Masterclass Series
Mumbai, December 17th 2024: Jenburkt Pharmaceuticals Limited, a 40-year-old pharmaceutical organization listed on the Bombay Stock Exchange and a pioneer in pain management, announced an unprecedented, first-time-ever educational partnership with premier institute National Institute of Mental Health and Neurosciences (NIMHANS), marking a significant milestone in neuropathy research and medical education in India. Neuropathy, or nerve damage, often remains undiagnosed or misdiagnosed, leaving...